Skip to content

Our Approach

George Medicines is not a traditional drug development company. We take established leading treatment options to formulate single pill multi-mechanism combinations provided at novel doses, to treat the most prevalent and debilitating cardiometabolic conditions. Our fixed-dose combination medications provided at unique lower doses are designed to deliver the efficacy, tolerability, and simplified titration that most patients and healthcare providers need to reach their treatment goals. These new strategies in drug design and delivery offer the potential for long-term improvements in clinical outcomes and better adherence to treatment.

According to the World Health Organization (2003), only 50% of patients in developed countries who suffer from chronic diseases adhere to treatment recommendations. In developing countries, when taken together with poor access to health care, lack of appropriate diagnosis and limited access to medicines, poor adherence is threatening any effort to tackle chronic conditions such as hypertension. Using a low dose can often achieve much of the benefits, while avoiding many of the side effects, from a particular medicine. Combining multiple medicines can ensure a high efficacy overall.

Single-pill combinations for non-communicable diseases

George Medicines’ drug development programmes target non-communicable diseases (NCDs), the world’s leading causes of death and disability. Our innovative, single-pill, multi-mechanism combinations, in novel and unique dosage strengths, would reduce the need for patients to take multiple sets of pills daily and offer the potential for improvements in medication adherence.

NCDs are responsible for 71 per cent of global deaths annually. According to Access Accelerated 15 million people who die from NCDs are between 30 and 69 years old. Most of these are in low- and middle-income countries. The premature deaths of these individuals, during their most economically productive years, have a significant economic impact on these countries.

Affordability & Accessibility

By developing life-saving treatment combinations in a single pill, George Medicines provides products that are designed to be more affordable for patients, helping them live better and longer. We strive to make better treatments for all.

At George Medicines, we are committed to bring medicines to patients around the globe, including low and middle-income countries. Our corporate partnerships leverage deep understanding of local and regional healthcare systems, enabling our medicines to reach the patients who need them in the most economical way.

The George Medicines Business Model

Research from The George Institute

Optimal product selection & IP protection

Formulation development

Late stage clinical development & registration in key territories